Tirzepatide high -charging, launching severe weight loss after menopause

“This data is the first to show the joint use of Terzopatid’s treatment and a significant translation of menopause. The effectiveness direction for these two categories of drugs,” said Regina Kastaneda, a research colleague.

Hormonal changes associated with menopause often lead to increased fat in the abdomen, low muscle mass and changing energy expenses that lead to weight gain and put millions of women at the risk of heart disease and other serious health issues.

To confirm the hypothesis that the treatment of simultaneous menopause hormone enhances the effectiveness of the Terzopatid weight loss in women after menopause, the researchers conducted a real study using electronic medical records of 120 women after menopause for 18 months. The study included two groups: 40 women using menopause hormone treatment simultaneously with Tirzepatide and 80 women using Tirzepatide alone.

The results showed a significant loss of body weight for women who use Tirzepatide as well as the treatment of menopause hormone (17 %) compared to those who use Tirzepatide alone (14 %). In addition, a higher percentage of menopause (45 %) also has achieved at least 20 % of the total body weight loss, compared to 18 % of menopause hormone treatment.

“The information obtained through this new study provides important visions to develop more effective and personal weight management interventions to reduce the risk of weight gain from weight gain and obesity -related health complications. “This study emphasizes the urgent need for more research to understand how to make obesity medications and treat menopause together. This knowledge can greatly gain the health and well -being of millions of women after menopause. It also indicates the need for better strategies to make these treatments easier and available to those who need them.”

This research has been funded by the National Institutes of Health that finds multidisciplinary professions in the Women’s Health Research Scholarship and the Mayo Clinic Center for Women’s Health Research.